What is NewIcon?
NewIcon operates within the health technology sector, focusing on the development and deployment of sophisticated pharmacy automation systems. Their product suite includes automated dispensing and compounding systems engineered for hospitals and pharmacies. By integrating advanced software and robotics, NewIcon aims to globally optimize pharmaceutical services, catering to healthcare providers that prioritize cutting-edge Finnish health technology. The company's commitment lies in empowering healthcare institutions to streamline their operations via innovative automation solutions, thereby improving patient care and operational efficiency.
How much funding has NewIcon raised?
NewIcon has raised a total of $7.5M across 2 funding rounds:
Unspecified
$2.9M
Angel/Seed
$4.7M
Unspecified (2014): $2.9M with participation from Finnish Industry Investment
Angel/Seed (2017): $4.7M, investors not publicly disclosed
Key Investors in NewIcon
Finnish Industry Investment
Finnish Industry Investment, also known as Invest in Finland, is the official investment promotion agency supporting international companies establishing operations in Finland. They offer industry insights and practical support across sectors like bioeconomy, health, and software, aiming to facilitate sustainable growth and innovation.
What's next for NewIcon?
With the recent major strategic investment and substantial overall capital raised, NewIcon is well-positioned for an accelerated growth trajectory. This enterprise-level funding is likely to fuel further research and development into next-generation automation technologies, expanding market reach, and enhancing its service offerings to hospitals and pharmacies. The company's focus on Finnish health technology innovation suggests a strategic push to solidify its position as a leader in the global pharmacy automation market, potentially exploring new partnerships and technological advancements to meet the evolving demands of the healthcare industry.
See full NewIcon company page
